Author

Rajendra Kumar

Johns Hopkins UniversityORCID 0000-0002-2845-8115Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:statistical model· 1

Frequent Co-Authors

Michael Anthony CarducciiD· 2 shared Abhishek ShettyiD· 1 shared Adel MandliD· 1 shared Brian P. HanrattyiD· 1 shared Channing Judith PalleriD· 1 shared D. Marc Rosen· 1 shared Deven TopiwalaiD· 1 shared Hugh Young RienhoffiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Michael Anthony CarducciORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyThe FASEB JournalPeer-reviewedJan 28, 2025

CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptor.

Rajendra Kumar, Janet Mendonca, Abhishek Shetty…·Sushant K. Kachhap

This study shows CRM1 regulates androgen receptor stability and DNA repair in prostate cancer, suggesting combination therapy with CRM1 and DNA repair inhibitors could be effective.

2 citations

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 17, 2024

Differential response to LSD1 inhibition in prostate cancer reveals a YAP1 vulnerability in the neuroendocrine subtype

Sumer Jasmine, Rajendra Kumar, Sunghyun Kim…·William Nathaniel Brennen

This paper shows that LSD1 inhibition is effective against neuroendocrine prostate cancer (NEPC) and that combining it with YAP/TEAD inhibition enhances treatment efficacy.

7 citations

humanbulk RNA-seq

𝕏 PostBluesky